50242-0260
Phesgo
Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf
INJECTION, SOLUTION
Subcutaneous
HYALURONIDASE (HUMAN RECOMBINANT)
20000.0
U/10mL

PERTUZUMAB
600.0
mg/10mL

TRASTUZUMAB
600.0
mg/10mL
50242-0260-01
1 VIAL, SINGLE-DOSE in 1 CARTON (50242-260-01) > 10 mL in 1 VIAL, SINGLE-DOSE
June 29, 2020

50242-0260-86
1 VIAL, SINGLE-DOSE in 1 CARTON (50242-260-86) > 10 mL in 1 VIAL, SINGLE-DOSE
May 3, 2021
Immunotherapy
Monoclonal Antibody
HER2
 
 
In Use